Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parvanova, A.
Right arrow Articles by Ruggenenti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parvanova, A.
Right arrow Articles by Ruggenenti, P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 25:2361, 2002
© 2002 by the American Diabetes Association, Inc.

Letters: Observations
Letter

Hyperhomocysteinemia and Increased Risk of Retinopathy

A cross-sectional, case-control study in patients with type 2 diabetes

Aneliya Parvanova, MD1, Ilian Iliev, MD1,2, Borislav D. Dimitrov, MD, MSc1,3, Federica Arnoldi, Res Nurse1, Jelka Zaletel, MD1,5, Giuseppe Remuzzi, MD, FRCP1,4 and Piero Ruggenenti, MD1,4

1 Clinical Research Center for Rare Diseases "Aldo e Cele Daccò," Mario Negri Institute for Pharmacological Research, Bergamo, Italy
2 Unit of Opthalmology, Azienda Ospedaliera, Ospedali Riuniti, Bergamo, Italy
3 Department of Social Medicine and Health Management, Medical University, Plovdiv, Bulgaria
4 Unit of Nephrology, Azienda Ospedaliera, Ospedali Riuniti, Bergamo, Italy
5 Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Center, Ljubljana, Slovenia

Increased total plasma homocysteine (tHcy) level—secondary to excessive alcohol intake, cigarette smoking, or deficiency of methylene-tetrahydrofolate reductase—is one new identified risk factor for atherosclerotic cardiovascular diseases and for macrovascular complications of diabetes (1,2). Homocysteine (Hcy)-induced vascular damage is probably initiated by reactive oxygen species formed during Hcy auto-oxidation in plasma and results in decreased nitric oxide production, platelet activation, impaired arterial vasodilatation, and isolated systolic hypertension (1).

To assess whether hyperhomocysteinemia is also an independent risk factor for microvascular complications, we cross-sectionally studied the relations among tHcy levels, diabetic retinopathy (diagnosed by indirect ophtalmoscopy and retinal photography), insulin sensitivity and glomerular filtration rate (measured by euglycemic-hyperinsulinemic clamp and unlabeled iohexol plasma clearance, respectively), lipid profile, overnight urinary albumin excretion rate, and other clinical and laboratory parameters in 11 consecutive type 2 diabetic subjects with retinopathy (case subjects) and 26 age- and sex-matched type 2 diabetic subjects without retinopathy (control subjects). To limit the confounding effect of decreased tHcy clearance associated with advanced renal insufficiency, only subjects with serum creatinine <=2.0 mg/dl were considered. Patients gave written informed consent. The Ethical Committee of the Clinical Research Center, "Aldo & Cele Daccò," Mario Negri Institute, Italy, approved the protocol.

Altogether, 1 case subject had proliferative and 10 subjects had nonproliferative diabetic retinopathy. Prevalence of hyperhomocysteinemia (54.5 vs. 26.9%) and tHcy levels (17.2 ± 6.6 vs. 12.3 ± 4.1 µmol/l, P < 0.05) were higher in case than in control subjects. Case subjects also had longer diabetes duration (171 ± 96 vs. 73 ± 75 months), lower BMI (27 ± 5 vs. 31 ± 5 kg/m2), higher systolic blood pressure (155 ± 15 vs. 145 ± 12 mmHg) and albumin excretion rate (412 ± 600 vs. 212 ± 385 µg/min), and were more frequently micro- or macroalbuminuric (P < 0.05 for all comparisons). Age, sex distribution (with a male prevalence in both groups), smoking habit, HbA1c level, diastolic blood pressure, insulin sensitivity, lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides), serum creatinine, glomerular filtration rate, and antidiabetic and antihypertensive treatments were comparable in both groups. At univariate logistic regression analysis, only longer duration of diabetes, higher systolic blood pressure, and increased tHcy levels were associated with diabetic retinopathy. Glomerular filtration rate was not related to diabetic retinopathy (P > 0.05). At multivariate forward stepwise logistic regression, tHcy (ß = 4.47, P = 0.019), diabetes duration (ß = 2.10, P = 0.009), and systolic blood pressure (ß = 0.09, P = 0.020) were independent markers of diabetic retinopathy. Altogether, they predicted the disease with 86.5% accuracy (model {chi}2 = 23.19, P = 0.0001).

Thus, hyperhomocysteinemia is associated with an increased risk of diabetic retinopathy and clusters with longer diabetes duration and systolic hypertension as an independent marker. The finding that case subjects had higher albumin excretion rates than control subjects and were more frequently micro- or macroalbuminuric suggests that hyperhomocysteinemia is also an indicator of overall microvascular damage in type 2 diabetes.

Hcy evaluation may serve to identify diabetic patients predisposed to sight-threatening complications who may benefit from intensified screening and treatment strategies, including folic acid and vitamin B6 and B12 supplements, aimed to limit or prevent the incidence and progression of micro- and macrovascular complications.

Footnotes

Address correspondence to Piero Ruggenenti, MD, "Mario Negri" Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni, 11-24125 Bergamo, Italy. E-mail: manuelap{at}marionegri.it.

References

  1. Gerhard GT, Duell B: Homocysteine and atherosclerosis. Curr Opinion Lipidol 10: 417–428, 1999[Medline]
  2. Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med 338: 1042–1050, 1998[Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
K. Yoshioka, T. Yoshida, Y. Takakura, A. Kogure, T. Umekawa, H. Toda, and T. Yoshikawa
No Association Between the MTHFR Gene Polymorphism and Diabetic Retinopathy in Type 2 Diabetic Patients Without Overt Nephropathy: Response to Maeda et al.
Diabetes Care, June 1, 2003; 26(6): 1947 - 1948.
[Full Text] [PDF]

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parvanova, A.
Right arrow Articles by Ruggenenti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parvanova, A.
Right arrow Articles by Ruggenenti, P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum